Table 2.
Overall drug utilization in total number of prescriptions of the study population
| Drugs prescribed | In-hospital (n=1120) | At discharge (n=877) |
|---|---|---|
| Cardiac drugs | ||
| Antiplatelets | 964 (86.07) | 716 (81.64) |
| Anticoagulants | 623 (55.62) | 24 (27.37) |
| Thrombolytics | 133 (11.87) | 0 |
| Antianginals | 638 (56.96) | 347 (39.58) |
| Statins | 903 (80.62) | 672 (76.62) |
| ACE inhibitors | 795 (70.98) | 568 (64.77) |
| Angiotensin receptor blocker | 12 (1.07) | 11 (1.25) |
| Beta blockers | 471 (42.05) | 566 (64.54) |
| Alpha and beta blockers | 225 (20.09) | 192 (21.89) |
| Diuretics | 738 (65.89) | 483 (55.07) |
| Antiarrhythmics | 47 (4.2) | 13 (1.48) |
| Calcium channel blockers | 121 (10.8) | 71 (8.1) |
| Inotropes | 356 (31.79) | 134 (15.28) |
| Noncardiac drugs | ||
| Oxygen | 467 (41.7) | 0 |
| Bronchodilators | 226 (20.18) | 47 (5.36) |
| Intravenous fluids | 381 (34.02) | 0 |
| Antidiabetics | 180 (16.07) | 144 (16.42) |
| Antibiotics | 433 (38.66) | 139 (15.85) |
| Centrally acting drugs | 183 (16.34) | 43 (4.9) |
| Antiulcer drugs | 938 (83.75) | 616 (70.24) |
| Antihistamines | 171 (15.27) | 5 (0.57) |
| Laxatives | 127 (11.34) | 11 (1.25) |
| Mucokinetics | 134 (11.96) | 23 (2.62) |
| Antiemetics | 110 (9.82) | 12 (1.37) |
| Antidiarrheals | 38 (3.39) | 4 (0.46) |
| Analgesic, anti-inflammatory, and muscle relaxant | 86 (7.68) | 84 (9.58) |
| Thyroid drugs | 11 (0.09) | 12 (1.37) |
| Vitamin supplements | 298 (26.61) | 388 (44.24) |
| Overall electrolyte | 394 (35.18) | 131 (14.94) |
| Erectile dysfunction drugs | 48 (4.29) | 37 (4.22) |
| Antivertigo | 15 (1.34) | 5 (0.57) |
| Ursodeoxycholic acid | 11 (0.09) | 5 (0.57) |
| Benign prostatic hyperplasia drug | 1 (0.01) | 1 (0.1) |
ACE=Angiotensin-converting enzyme